Molecular Basis of a Dominant SARS-CoV-2 Spike-Derived Epitope Presented by HLA-A*02:01 Recognised by a Public TCR

The data currently available on how the immune system recognizes the SARS-CoV-2 virus is growing rapidly. While there are structures of some SARS-CoV-2 proteins in complex with antibodies, which helps us understand how the immune system is able to recognise this new virus, we are lacking data on how T cells are able to recognize this virus. T cells, especially the cytotoxic CD8+ T cells, are critical for viral recognition and clearance. Here we report the X-ray crystallography structure of a T cell receptor, shared among unrelated individuals (public TCR) in complex with a dominant spike-derived CD8+ T cell epitope (YLQ peptide). We show that YLQ activates a polyfunctional CD8+ T cell response in COVID-19 recovered patients. We detail the molecular basis for the shared TCR gene usage observed in HLA-A*02:01+ individuals, providing an understanding of TCR recognition towards a SARS-CoV-2 epitope. Interestingly, the YLQ peptide conformation did not change upon TCR binding, facilitating the high-affinity interaction observed.

[1]  V. Appay,et al.  Impaired Priming of SARS-CoV-2-Specific Naive CD8+ T Cells in Older Subjects , 2021, Frontiers in Immunology.

[2]  C. Szeto,et al.  Protein purification and crystallization of HLA-A∗02:01 in complex with SARS-CoV-2 peptides , 2021, STAR Protocols.

[3]  P. Dormitzer,et al.  BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans , 2021, Nature.

[4]  M. Koopmans,et al.  SARS-CoV-2 variants of concern partially escape humoral but not T cell responses in COVID-19 convalescent donors and vaccine recipients , 2021, Science Immunology.

[5]  T. Schumacher,et al.  Identification and characterization of a SARS-CoV-2 specific CD8+ T cell response with immunodominant features , 2021, Nature Communications.

[6]  S. Kent,et al.  CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuity , 2021, Immunity.

[7]  C. Szeto,et al.  CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope cross-react with selective seasonal coronaviruses , 2021, Immunity.

[8]  M. Nielsen,et al.  SARS-CoV-2 genome-wide T cell epitope mapping reveals immunodominance and substantial CD8+ T cell activation in COVID-19 patients , 2021, Science Immunology.

[9]  R. Valenta,et al.  SARS-CoV-2 mutations in MHC-I-restricted epitopes evade CD8+ T cell responses , 2021, Science Immunology.

[10]  S. Mallal,et al.  Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases , 2021, Cell Reports Medicine.

[11]  C. Szeto,et al.  The presentation of SARS-CoV-2 peptides by the common HLA-A∗02:01 molecule , 2021, iScience.

[12]  A. Casadevall,et al.  SARS-CoV-2-specific CD8+ T cell responses in convalescent COVID-19 individuals. , 2021, The Journal of clinical investigation.

[13]  C. Szeto,et al.  TCR Recognition of Peptide–MHC-I: Rule Makers and Breakers , 2020, International journal of molecular sciences.

[14]  S. Mallal,et al.  Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases , 2020, bioRxiv.

[15]  G. A. Efimov,et al.  SARS-CoV-2 Epitopes Are Recognized by a Public and Diverse Repertoire of Human T Cell Receptors , 2020, Immunity.

[16]  Meriem Bensouda Koraichi,et al.  Longitudinal high-throughput TCR repertoire profiling reveals the dynamics of T-cell memory formation after mild COVID-19 infection , 2020, bioRxiv.

[17]  B. Jakobsen,et al.  TCRs with Distinct Specificity Profiles Use Different Binding Modes to Engage an Identical Peptide–HLA Complex , 2020, The Journal of Immunology.

[18]  E. Dong,et al.  An interactive web-based dashboard to track COVID-19 in real time , 2020, The Lancet Infectious Diseases.

[19]  L. Loh,et al.  Broad CD8+ T cell cross-recognition of distinct influenza A strains in humans , 2018, Nature Communications.

[20]  Alessandro Sette,et al.  The Immune Epitope Database (IEDB): 2018 update , 2018, Nucleic Acids Res..

[21]  K. Garcia,et al.  T cell receptor cross-reactivity expanded by dramatic peptide/MHC adaptability , 2018, Nature Chemical Biology.

[22]  N. Cowieson,et al.  MX2: a high-flux undulator microfocus beamline serving both the chemical and macromolecular crystallography communities at the Australian Synchrotron , 2018, Journal of synchrotron radiation.

[23]  Andrew K. Sewell,et al.  Dual Molecular Mechanisms Govern Escape at Immunodominant HLA A2-Restricted HIV Epitope , 2017, Front. Immunol..

[24]  P. Doherty,et al.  Molecular basis for universal HLA-A*0201–restricted CD8+ T-cell immunity against influenza viruses , 2016, Proceedings of the National Academy of Sciences.

[25]  E. B. Clemens,et al.  Human influenza viruses and CD8(+) T cell responses. , 2016, Current opinion in virology.

[26]  Paul G. Thomas,et al.  Recovery from severe H7N9 disease is associated with diverse response mechanisms dominated by CD8+ T cells , 2015, Nature Communications.

[27]  Jonathan J Deeks,et al.  Cellular immune correlates of protection against symptomatic pandemic influenza , 2013, Nature Medicine.

[28]  Stephen J. Turner,et al.  Structural basis for enabling T-cell receptor diversity within biased virus-specific CD8+ T-cell responses , 2011, Proceedings of the National Academy of Sciences.

[29]  Randy J. Read,et al.  Overview of the CCP4 suite and current developments , 2011, Acta crystallographica. Section D, Biological crystallography.

[30]  G. Gao,et al.  Germ Line-governed Recognition of a Cancer Epitope by an Immunodominant Human T-cell Receptor* , 2009, The Journal of Biological Chemistry.

[31]  Marc Bonneville,et al.  Structural Bases for the Affinity-Driven Selection of a Public TCR against a Dominant Human Cytomegalovirus Epitope1 , 2009, The Journal of Immunology.

[32]  L. K. Ely,et al.  The molecular basis of TCR germline bias for MHC is surprisingly simple , 2009, Nature Immunology.

[33]  J. McCluskey,et al.  T-cell receptor bias and immunity. , 2008, Current opinion in immunology.

[34]  Randy J. Read,et al.  Phaser crystallographic software , 2007, Journal of applied crystallography.

[35]  Daniel C. Douek,et al.  Sharing of T cell receptors in antigen-specific responses is driven by convergent recombination , 2006, Proceedings of the National Academy of Sciences.

[36]  Katherine Kedzierska,et al.  Conserved T cell receptor usage in primary and recall responses to an immunodominant influenza virus nucleoprotein epitope. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[37]  J. Cabaniols,et al.  Most α/β T Cell Receptor Diversity Is Due to Terminal Deoxynucleotidyl Transferase , 2001, The Journal of experimental medicine.

[38]  R. Hartzman,et al.  Frequencies of HLA-A2 alleles in five U.S. population groups. Predominance Of A*02011 and identification of HLA-A*0231. , 2000, Human immunology.

[39]  A. Casrouge,et al.  A Direct Estimate of the Human αβ T Cell Receptor Diversity , 1999 .

[40]  J. Thompson,et al.  CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. , 1994, Nucleic acids research.

[41]  Collaborative Computational,et al.  The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.

[42]  Mark M. Davis,et al.  T-cell antigen receptor genes and T-cell recognition , 1988, Nature.

[43]  A. McMichael,et al.  Cytotoxic T-cell immunity to influenza. , 1983, The New England journal of medicine.

[44]  P. Emsley,et al.  Features and development of Coot , 2010, Acta crystallographica. Section D, Biological crystallography.

[45]  A. Casrouge,et al.  A direct estimate of the human alphabeta T cell receptor diversity. , 1999, Science.

[46]  Ballard,et al.  Overview of the CCP 4 suite and current developments , 2022 .